Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
Date:2/21/2013

ions in body weight and blood pressure. In addition, Lexicon initiated a study in type 2 diabetes patients with renal impairment.
  • Telotristat etiprate (LX1032):  Lexicon initiated a pivotal Phase 3 clinical trial of telotristat etiprate, an inhibitor of tryptophan hydroxylase that reduces peripheral serotonin production without affecting brain serotonin levels. The Phase 3 registrational trial is a 12-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of telotristat etiprate as a new treatment for carcinoid syndrome that is refractory to current therapy.  The study is expected to enroll approximately 105 patients.  Lexicon reported data from an open-label Phase 2 trial in which telotristat etiprate showed evidence of clinical benefit across several endpoints in carcinoid syndrome patients. Benefits included reductions in bowel movement frequency, decreased urinary 5-HIAA (a biomarker of serotonin synthesis), and improvements in patient-reported relief of symptoms. Lexicon received Orphan Drug designation for telotristat etiprate from the U.S. Food and Drug Administration (FDA) for the treatment of carcinoid syndrome, having previously obtained Fast Track designation from the FDA and Orphan Drug designation from the European Medicines Agency (EMA). In addition to ongoing development in carcinoid syndrome, Lexicon also initiated a Phase 2 proof-of-concept study of telotristat etiprate in patients with ulcerative colitis.
  • LX1033: Lexicon initiated a Phase 2 clinical trial of LX1033, an inhibitor of tryptophan hydroxylase that acts locally in the gastrointestinal tract to reduce serotonin production, in patients with diarrhea-predominant IBS (IBS-d). The Phase 2 trial is a randomized, double-blind, placebo-controlled study designed to evaluate the safe
    '/>"/>

  • SOURCE Lexicon Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Lexicon To Present At The BIO CEO & Investor Conference
    2. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
    3. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
    4. Lexicon to Provide Third Quarter 2012 Financial Results
    5. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
    6. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
    7. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
    8. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
    9. Lexicon to Provide Second Quarter 2012 Financial Results
    10. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
    11. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/26/2015)... 2015 LifeScienceIndustryResearch.com adds Global ... Class Innovations and Cost Optimization Plays Major Role ... Companies research report to the pharmaceuticals intelligence collection ... Global Pharma US & EU Outlook 2015 report, ... of non-core assets result in healthy cash position ...
    (Date:2/26/2015)... -- The report, "Bottled Water Processing ... Blow molder, Shrink wrapper), Technology (RO, UF, MF, ... Region - Trends & Forecasts to 2019", published ... processing market with analyses and projection of the ... also identifies the driving and restraining factors for ...
    (Date:2/26/2015)... PORTLAND, Ore. , Feb. 26, 2015 /PRNewswire-USNewswire/ ... providers will have the opportunity to participate in ... outcomes when the first independent U.S. psoriasis registry ... registry, a joint collaboration with the National Psoriasis ... drug safety reporting for secukinumab, a new biologic ...
    Breaking Medicine Technology:Global Pharma U.S. and EU Outlook 2015 Market Research Report 2Global Pharma U.S. and EU Outlook 2015 Market Research Report 3Global Pharma U.S. and EU Outlook 2015 Market Research Report 4Bottled Water Processing Market Worth $2,106.5 Million by 2019 2Bottled Water Processing Market Worth $2,106.5 Million by 2019 3Bottled Water Processing Market Worth $2,106.5 Million by 2019 4First independent U.S. psoriasis registry will track drug safety and effectiveness 2First independent U.S. psoriasis registry will track drug safety and effectiveness 3
    ... N.J., June 10, 2011 Unity Management Group, ... a Health Resource Company specializing in Physician and ... Technologies, along with Pharmacy Instrumentation, Calibration, Data Acquisition, ... pleased to announce today that (MCC) Metropolitan Computing ...
    ... BOCA RATON, Fla., June 10, 2011 ... U.S. Food and Drug Administration has granted final ... (ANDA) to market its generic version of Activella® ... to Activella® 1.0mg/0.5mg Tablets, as (Estradiol/Norethindrone Acetate 1.0mg/0.5mg) ...
    Cached Medicine Technology:Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 2Unity Management Group, MCC Announce Increased Contracts and Major Installations at US and South American Pharmaceutical Companies 3
    (Date:2/27/2015)... 2015 RDI-Engineering will be hosting an ... event on March 14, at Moreno Valley College. The ... how to use engineering software and tools, and a ... by Moreno Valley College’s Upward Bound Math and Science ... in hopes to encourage students to seek educational and ...
    (Date:2/27/2015)... Canadian, Oklahoma (PRWEB) February 27, 2015 ... run by the U.S. Drug Enforcement Agency (DEA). ... with local organizations continue to utilize the “Take-Back” ... listed by the FDA. , Eufaula Prescription Drug ... designated 1425 Industrial Drive in Eufaula, Oklahoma as ...
    (Date:2/27/2015)... Philanthropy is a continuous force restoring people’s ... help to restore that faith by helping the people in ... husband/wife Realtor team gives to the local children in need ... while others have been added as the need arose. , ... haven and counseling for women who have suffered physical and ...
    (Date:2/27/2015)... San Mateo, CA (PRWEB) February 27, 2015 ... five 2015 California Teachers of the Year. The gala ... helping all their students achieve both in and outside ... grade science instructor at Manhattan Beach Middle School, was ... , As the Presenting Sponsor of the California ...
    (Date:2/27/2015)... Austin, TX (PRWEB) February 27, 2015 ... University 3D printing survey is to explore the current ... economy. You are invited to contribute to the Survey ... Preliminary results reveal varied use among large and ... categories of companies. In a recent PwC and Manufacturing ...
    Breaking Medicine News(10 mins):Health News:RDI-Engineering Participates in STEM”U”LATE Your Mind Event to Host Educational Exhibition 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:Mr. And Mrs. Smits Proves That Altruism Works All Year Round 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 2Health News:California Casualty is Presenting Sponsor of California Program Honoring Educators That Make a Difference 3Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 3
    ... egg should be avoided by patients with high cholesterol ... has developed a egg variety that does no ... diabetes is growing especially in Indian sub-continent. 'The modified ... S.K. Taneja, a professor in the university's Department of ...
    ... are increasingly recognized as important factors in disease ... drug resistance. However, the distinction of co-infecting site ... been // ficult with traditional methods based on ... ,Trypanosoma brucei , a protozoan parasite transmitted by ...
    ... can be used to reveal the strength of bones ... the likelihood of fracturing a particular bone, an article ... says. ,Scientists have developed a laser imaging technique ... density thereby predicting future risk of fracturing that particular ...
    ... from Italy have found a new urine test which detects ... test which is proved to be 90% accurate is used ... of patients. The results of the study have been published ... would be very useful for detecting cancer in smokers and ...
    ... perception is dependent on the specialized cells of the eye. ... a research state that our perception of color is controlled ... ,The number of color-sensitive cones in the human retina differs ... perceive colors the same way. The study has shown that ...
    ... In a novel initiative to combat the spread of ... joint initiative// of the William J. Clinton Foundation and ... entered into a partnership with Nickelodeon's award-winning Let's Just ... forces on a comprehensive media and public awareness campaign, ...
    Cached Medicine News:Health News:Fluorescent markers to distinguish Trypanosoma brucei strains causing Sleeping Sickness 2Health News:Urine testing for telomerase enzyme for bladder cancer diagnosis 2Health News:Seeing Is Believing Does Not Hold Good For Color Perception 2Health News:A New Initiative To Fight Childhood Obesity 2
    Each slide contains a gram positive control of Staphylococcus aureus ATCC ® 25923 and a gram negative control of Escherichia coli ATCC ® 25922....
    Each slide contains an A.F.B. positive staining control of Mycobacterium scrofulaceum ATCC ® 19981 in simulated sputum and an A.F.B. negative staining control of Escherichia coli ATCC ® 25922...
    ... Plate Capability The Equalizer 384 includes ... and equal tip spacing, choice of two software ... addition, this model allows you to evenly space ... accessing many gels and for use with 384 ...
    ... 384 Well Plate Capability The Equalizer ... original Equalizerexpandable and equal tip spacing, choice of ... capabilities. In addition, this model allows you to ... loading and accessing many gels and for use ...
    Medicine Products: